| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV-IMMUNOL-030409-101250 |
| P698 | PubMed publication ID | 19947883 |
| P50 | author | Claudia Kemper | Q73090566 |
| P2093 | author name string | John P Atkinson | |
| Dennis E Hourcade | |||
| P2860 | cites work | The consensus coding sequences of human breast and colorectal cancers | Q27861035 |
| P304 | page(s) | 131-155 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Annual Review of Immunology | Q567362 |
| P1476 | title | Properdin: emerging roles of a pattern-recognition molecule | |
| P478 | volume | 28 |
| Q38558930 | A journey through the lectin pathway of complement-MBL and beyond |
| Q37185654 | An Inhibitor of the Alternative Pathway of Complement in Saliva of New World Anopheline Mosquitoes. |
| Q39253584 | An overview of the synergy and crosstalk between pentraxins and collectins/ficolins: their functional relevance in complement activation. |
| Q26864089 | Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis |
| Q35149952 | Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesis |
| Q26850135 | Antimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damage |
| Q38234314 | Bacteria under stress by complement and coagulation. |
| Q36718295 | Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice |
| Q39869411 | Bovine viral diarrhea virus structural protein E2 as a complement regulatory protein |
| Q36049951 | C1q protein binds to the apoptotic nucleolus and causes C1 protease degradation of nucleolar proteins |
| Q64116378 | CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3 |
| Q30415634 | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis |
| Q34481071 | Complement System Part I - Molecular Mechanisms of Activation and Regulation |
| Q92084523 | Complement System in Cutaneous Squamous Cell Carcinoma |
| Q37288362 | Complement activation: an emerging player in the pathogenesis of cardiovascular disease |
| Q34162421 | Complement and viral pathogenesis |
| Q34067107 | Complement control protein factor H: the good, the bad, and the inadequate. |
| Q33642649 | Complement factor P is a ligand for the natural killer cell-activating receptor NKp46. |
| Q40122524 | Complement factor P: promoting the antibacterial activity of natural killer cells. |
| Q39371134 | Complement in Kidney Transplantation |
| Q37940918 | Complement in cancer and cancer immunotherapy |
| Q33432423 | Complement in disease: a defence system turning offensive |
| Q36756850 | Complement in immune and inflammatory disorders: pathophysiological mechanisms |
| Q38991044 | Complement in removal of the dead - balancing inflammation |
| Q38362621 | Complementing the Sugar Code: Role of GAGs and Sialic Acid in Complement Regulation |
| Q27026513 | Control of adaptive immunity by the innate immune system |
| Q37959890 | Crosstalk between complement and toll-like receptors |
| Q26852163 | Current Understanding of the Role of Complement in IgA Nephropathy |
| Q34455125 | Defining the complement biomarker profile of C3 glomerulopathy |
| Q26865903 | Do antimicrobial peptides and complement collaborate in the intestinal mucosa? |
| Q35240062 | Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? |
| Q35841122 | Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes |
| Q38991026 | Endothelial cells: source, barrier, and target of defensive mediators |
| Q41876336 | Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression |
| Q36016836 | Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascade. |
| Q55080454 | Human Properdin Modulates Macrophage: Mycobacterium bovis BCG Interaction via Thrombospondin Repeats 4 and 5. |
| Q42370133 | Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity |
| Q87661492 | IFN-γ-producing NKT cells exacerbate sepsis by enhancing C5a generation via IL-10-mediated inhibition of CD55 expression on neutrophils |
| Q33764140 | Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease |
| Q90265983 | Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b |
| Q36022738 | Interactions between coagulation and complement--their role in inflammation |
| Q36509318 | Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency |
| Q37577978 | Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake. |
| Q38785657 | Monomeric C-reactive protein inhibits renal cell-directed complement activation mediated by properdin |
| Q54416095 | Myeloperoxidase directs properdin-mediated complement activation. |
| Q31117454 | NOD2-mediated suppression of CD55 on neutrophils enhances C5a generation during polymicrobial sepsis |
| Q34172424 | Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement |
| Q37851796 | Native properdin binds to Chlamydia pneumoniae and promotes complement activation |
| Q39598946 | Natural IgM antibodies are involved in the activation of complement by hypoxic human tubular cells |
| Q44067374 | Next-Generation Sequencing and the Crustacean Immune System: The Need for Alternatives in Immune Gene Annotation |
| Q50961996 | Non-specific adsorption of complement proteins affects complement activation pathways of gold nanomaterials. |
| Q28082379 | On the Functional Overlap between Complement and Anti-Microbial Peptides |
| Q38155650 | Overview of complement activation and regulation |
| Q84301195 | Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators |
| Q38645385 | Potential Roles for C1 Inhibitor in Transplantation |
| Q35864604 | Properdin Contributes to Allergic Airway Inflammation through Local C3a Generation |
| Q40222861 | Properdin Levels in Individuals with Chemotherapy-Induced Neutropenia |
| Q37717987 | Properdin and factor H production by human dendritic cells modulates their T-cell stimulatory capacity and is regulated by IFN-γ. |
| Q37612601 | Properdin binding to complement activating surfaces depends on initial C3b deposition |
| Q38118454 | Properdin in complement activation and tissue injury |
| Q35037612 | Properdin levels in human sepsis |
| Q28069187 | Properdin: a tightly regulated critical inflammatory modulator |
| Q40138935 | Prospective observational study in two Dutch hospitals to assess the performance of inflammatory plasma markers to determine disease severity of viral respiratory tract infections in children |
| Q34320277 | RETRACTED: Properdin homeostasis requires turnover of the alternative complement pathway |
| Q34072846 | Role and mechanism of action of complement in regulating T cell immunity |
| Q38633062 | Role of complement in IgA nephropathy |
| Q34708606 | Roles of adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in mice |
| Q36368198 | Secondary cell wall polymers of Enterococcus faecalis are critical for resistance to complement activation via mannose-binding lectin |
| Q99254843 | Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement |
| Q27696183 | Structural basis for sialic acid-mediated self-recognition by complement factor H |
| Q30543168 | Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin. |
| Q38562102 | Structural insights on complement activation. |
| Q24328755 | Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase |
| Q26768534 | Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway |
| Q64248384 | The Natural Cytotoxicity Receptors in Health and Disease |
| Q34137841 | The complement system |
| Q84980842 | The odd couple: A fresh look at autoimmunity and immunodeficiency |
| Q49721910 | The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation? |
| Q42285785 | The role of properdin in zymosan- and Escherichia coli-induced complement activation |
| Q49947954 | The role of the alternative pathway of complement activation in glomerular diseases |
| Q89166249 | Timing and mechanism of conceptus demise in a complement regulatory membrane protein deficient mouse |
| Q41619655 | Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin |
| Q35949991 | Understanding the role of host hemocytes in a squid/vibrio symbiosis using transcriptomics and proteomics |
| Q37201329 | Vitellogenin recognizes cell damage through membrane binding and shields living cells from reactive oxygen species. |
| Q90429892 | Xenotransplantation: Progress Along Paths Uncertain from Models to Application |
Search more.